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Effective approaches to neuropsychiatric disorders
require detailed understanding of the cellular compo-
sition and circuitry of the complex mammalian brain.
Here, we present a paradigm for deconstructing the
diversity of neurons defined by a specific neurotrans-
mitter using a microfluidic dynamic array to simulta-
neously evaluate the expression of 96 genes in single
neurons. With this approach, we successfully identi-
fied multiple molecularly distinct dopamine neuron
subtypes and localized them in the adult mouse
brain. To validate the anatomical and functional cor-
relates of molecular diversity, we provide evidence
that one Vip+ subtype, located in the periaqueductal
region, has a discrete projection field within the
extended amygdala. Another Aldh1a1+ subtype,
located in the substantia nigra, is especially vulner-
able in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyri-
dine (MPTP) model of Parkinson’s disease. Overall,
this rapid, cost-effective approach enables the iden-
tification and classification of multiple dopamine
neuron subtypes, with distinct molecular, anatom-
ical, and functional properties.
INTRODUCTION
The mammalian CNS is an extremely heterogeneous organ
composed of hundreds of neuronal and nonneuronal cell types
(Ng et al., 2009). There is an urgent need to transition from cell
groups, traditionally defined by cytology and anatomy, to molec-
ularly defined cell types in order to generate a comprehensive
catalog of the mammalian CNS (Bota and Swanson, 2007; Fish-
ell and Heintz, 2013). In this regard, several in situ hybridization
and transgene-profiling studies have served as an important
step in classification of neurons in given brain regions (Shimogori
et al., 2010; Siegert et al., 2009).
The next important step toward classifying cellular diversity
requires the analysis of a multitude of markers with single-cell
resolution. Molecular definition of neurons should rely on a poly-930 Cell Reports 9, 930–943, November 6, 2014 ª2014 The Authorsthetic approach, rather than stochastically expressed markers
(Bota and Swanson, 2007). This transition is mandatory for accu-
rately defining neuronal circuitry and its relation to complex neu-
ral functions and behaviors. An ideal approach to investigate
neuronal diversity would allow a quick, reliable, and quantitative
assessment of the gene-expression profile of single neurons
obtained from the mammalian brain. Although recent reports of
single-cell transcriptomics have been published, this approach
is cost prohibitive and has yet to reach its maturity before being
broadly applicable to the mammalian CNS (Macaulay and Voet,
2014; Tang et al., 2010; Xue et al., 2013). As an alternative tech-
nology to simultaneously profilemultiple genes from a single cell,
we used a microfluidic chip array to investigate neuronal diver-
sity from mouse brain.
We focused on the investigation of the clinically important
midbrain dopaminergic (DA) system. Midbrain DA neurons influ-
ence a large spectrum of behaviors, and DA dysfunction is
prominently implicated in a wide variety of disorders including
Parkinson’s disease (PD), schizophrenia, attention deficit hyper-
activity disorder (ADHD), obsessive-compulsive disorder, addic-
tion, and depression, together affecting tens of millions of
people. How a small group of neurons, constituting less than
1% of brain neuronal populations, can account for such diverse
physiological functions has been a subject of interest since their
discovery.We hypothesized thatmultiplemolecularly distinct DA
subtypes could be partly responsible for the functional diversity
of the DA system.
During embryonic development, midbrain DA neurons are
derived from the Shh+ floor plate (FP) (Blaess et al., 2011; Hayes
et al., 2011; Joksimovic et al., 2009; Kittappa et al., 2007). FP
progenitors already display some heterogeneity, in terms of
gene expression and proclivity to contribute to distinct nuclei
(Blaess et al., 2011; Hayes et al., 2011; Joksimovic et al., 2009;
Walle´n et al., 1999). Immature DA neurons migrate from the ven-
tricular zone into the mantle and express a series of transcription
factors and other genes, some of which are heterogeneously ex-
pressed in the nascent DA cohort (Ang, 2006; Chung et al., 2010;
Di Salvio et al., 2010a; Smidt and Burbach, 2007; Smits et al.,
2013). Thus, the earliest aspects of DA neuron heterogeneity
appear to be established in the early embryo, although it is likely
that subsequent maturation events build on, or refine, DA hetero-
geneity. This model is akin to that proposed for the generation of
cortical interneuron lineages, wherein embryonic cardinal
classes are established, and sequentially refined, to generate
the full repertoire of interneurons (Kepecs and Fishell, 2014).
When considering the possibility of distinct postnatal DA
neuron populations, the overwhelming literature is based on
anatomical classification of midbrain DA neurons to three clus-
ters: the substantia nigra pars compacta (SNc) (A9), the ventral
tegmental area (VTA) (A10), and a third smaller cluster, found in
the retrorubral area (RR) (A8). Accordingly, several studies
have addressed the molecular heterogeneity of DA neurons in
anatomically defined SNc versus VTA populations with microar-
ray analysis (Chung et al., 2005; Greene et al., 2005; Grimm et al.,
2004). Although informative, these studies rely on the premise
that the SNc and VTA are composed of molecularly homoge-
neous populations. Considering the diverse functions of this
neurotransmitter system and recent reports of physiological
and functional heterogeneity (Darvas and Palmiter, 2009; Di
Salvio et al., 2010b; Ekstrand et al., 2014; Guzman et al., 2010;
Lammel et al., 2008, 2012; Margolis et al., 2006a, 2006b; Stama-
takis et al., 2013; Tye et al., 2011), we postulated the existence of
several molecularly distinct DA neuron subtypes, which may not
necessarily be segregated anatomically but rather may be inter-
mingled with one another. Providing the molecular identity of DA
neuron subtypes would have meaningful implications for (1)
targeted therapeutics of the DA system, (2) understanding the
differential vulnerability of DA neurons, (3) developing more-
accurate stem-cell- and induced-pluripotent-stem-cell-derived
DA neurons, and (4) a deeper understanding of the DAergic sys-
tem by providing points of genetic access, thus allowing genetic
dissection of this neurotransmitter system.
RESULTS
Comprehensive Single-Cell Gene-Expression Profile of
Midbrain Dopamine Neurons
To redefine the DA system on a molecular basis, we devised
a neuroanatomically unbiased systematic approach to profile
single midbrain DA neurons. We opted for a 96.96 dynamic array
to evaluate 96 cells, each for the expression of 96 key genes,
an approach used previously to discriminate stem cell identities
(Buganim et al., 2012; Guo et al., 2010). We selected 96 gene
candidates based on reported differential expression between
SNc and VTA (Chung et al., 2005; Greene et al., 2005; Grimm
et al., 2004), with a positive bias toward genes with validated
midbrain mRNA expression as shown by in situ hybridization
in public databases (Table S1). In addition, we evaluated the
expression of housekeeping genes (Actb, Gapdh, and Hprt),
genes linked to PD (Atp13a2, Lrrk2, Park2, Park7, Pink1, and
Snca), as well as validated DA neuronal markers (Ddc, Th,
Slc6a3, and Slc18a2). All primers used were prevalidated using
serial dilution of commercial reference samples. To isolate single
DA neurons, we grossly dissected and dissociated the midbrain
of postnatal day 4 (P4) Slc6a3::Cre, Ai9 mice. These mice have
been described previously (Ba¨ckman et al., 2006; Madisen
et al., 2010) and, in our hands, resulted in more than 95%
of Th+ midbrain DA neurons expressing tdTomato following
Cre-dependent recombination. Fluorescently labeled single cell
expressing tdTomato were sorted into 96-well plates with fluo-Crescence-activated cell sorting (FACS; Figure 1A). P4 was
selected as a specific time point, in part because of the technical
ease of FACS at this stage (Arlotta et al., 2005). Supporting
this choice, it has been argued that neuronal molecular identity
is established shortly after cells exit their last mitotic cycle
(Fishell and Heintz, 2013). Indeed, the vast majority of markers
that we selected are expressed in the developing embryo or in
the neonate, supporting P4 as a meaningful time point (Hoekstra
et al., 2013; Veenvliet et al., 2013).
In the initial experiment, 87 single cells were sorted in a 96-
well plate for gene-expression analysis (Figure 1B). The remain-
ing nine wells included a brain cDNA dilution series to generate
a standard curve. The Biomark microfluidics chip allows
the combination of samples and primer probe sets for 9,216
quantitative RT-PCR reactions with cycle threshold (Ct) values
as output (Figure S1). For quality control purposes, the melting
curve of every reaction was determined, and every reaction with
a peak falling outside the expected value was removed from the
analysis (examples of standard curve and melting curve are pro-
vided in Figure S2). This experiment was replicated by two other
arrays filled with single cells sorted from two additional mice.
Using a cutoff criterion of two SDs away from the median of
the housekeeping gene Gapdh and key DA neurons defining
genes Th, Slc6a3 (Dat), Slc18a2 (Vmat2), and Ddc (Aaad), we
removed all cells exhibiting a weak and unreliable expression.
Altogether, we were left with 159 DA neurons for further anal-
ysis, and the complete expression profile of these cells is pro-
vided in Figure S3. All these neurons had expression of key
transcription factors such as Foxa1, En1/2, Lmx1b, Pitx3, and
Nr4a2; because the combinatorial expression of these tran-
scription factors is unique to midbrain DA neurons, their expres-
sion confirms the absence of hypothalamic DA neurons in the
FACS-sorted cells. Additionally, all samples had virtually unde-
tectable levels of Gad1, confirming the absence of GABAergic
neurons.
From gene-expression data (Figures 1B and S3), it is apparent
that a large number of genes are expressed in all DA neurons.
The genes expressed in most DA neurons include PD-linked
genes Atp13a2, Lrrk2, Park2, Park7, and Pink1, as well as the
transcription factors Foxa1, En1/2, Lmx1b, Pitx3, and Nr4a2. In
contrast to these uniformly expressed genes, several genes
are differentially expressed between individual DA neurons. As
an approach for investigating molecular heterogeneity of DA
populations, we used an unbiased coefficient similarity hierarchi-
cal clustering analysis to parcel these cells according to their
gene-expression profile (Figures 1B and S4). This analysis re-
vealed the presence of two main clusters that could be further
divided into a total of six molecularly distinct DA subtypes (Fig-
ure 2A). Out of 159 cells, 55 cells (35%) belong to the first cluster,
98 cells (61%) were assigned to the second cluster, whereas six
cells (4%) could not be assigned. The first cluster can be subdi-
vided into two subtypes, here referred to as DA1A and DA1B,
which are composed of 33 cells (21%) and 22 cells (14%),
respectively. The second cluster can be subdivided into four
molecularly distinct subtypes labeled DA2A (18%), DA2B (23%),
DA2C (12%), and DA2D (9%). Interestingly, these six molecular
subtypes were represented in a roughly similar proportion in all
three microfluidic arrays (Figure 2A).ell Reports 9, 930–943, November 6, 2014 ª2014 The Authors 931
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Figure 1. High-Throughput Single-Cell Gene-Expression Analysis of Midbrain Dopamine Neurons
(A) The midbrain of postnatal day 4 Slc6a3::Cre; Ai9 was dissected and dissociated. Fluorescent (tdTomato+) single cells were FACS sorted into 96-well plates
and analyzed for the expression of 96 genes using Fluidigm Biomark system.
(B) A sample array in which the expression level of each gene is depicted on a logarithmic scale with red indicating low expression and yellow representing a high
expression. Unbiased clustering analysis revealed the presence of twomain clusters that could be further divided into a total of six molecularly distinct dopamine
(DA) neuron subtypes.We compared the relative gene-expression level, normalized
to Gapdh, of the two identified main clusters by subtracting the
average value of cells assigned to the second cluster to the
average value of cells assigned to the first cluster (Figure 2B).
Gapdh proved to be a reliable housekeeping gene because there
were significant correlations between this gene and other known
housekeeping genes, Actb (r = 0.939; n = 105; p < 0.0001) and
Hprt (r = 0.922; n = 105; p < 0.0001). This analysis revealed sig-
nificant differences between these clusters in the expression of
some key genes. For instance, Sox6, Slc6a3, Zdhhc2, and
Nrip3 have a higher expression in the first compared to the sec-
ond cluster. Interestingly, those four genes were previously re-
ported to have a higher expression in pooled cells of the SNc
compared to the VTA (illustrated in red in Figure 2B; see Table
S1 for references). In comparison, we found that Calb1,
Slc17a6, Cck, Calb2, and Efnb3 are five genes found to have a
higher expression in the second cluster. These five genes, like932 Cell Reports 9, 930–943, November 6, 2014 ª2014 The Authorsthe majority of genes overexpressed in the second cluster,
were previously associated with cells of the VTA (illustrated in
blue in Figure 2B; see Table S1 for references). It is important
to note that cells were not identified based on their neuroana-
tomical position, because the anatomical origin of each FACS-
sorted cell is undetermined. However, we can conclude that
the expression profile of cells from cluster 1 has more similarity
with the molecular signature of cells of the SNc, whereas cells
from cluster 2 have an expression profile related to the VTA.
This prediction is indeed borne out in subsequent anatomical
analysis, which shows that DA1A and DA1B (cluster 1) are more
localized to the SNc, whereas DA2A–DA2D (cluster 2) are prefer-
entially localized to the VTA.
Molecular Signature of Dopamine Neuron Subtypes
TheDA neuron subtypes defined by clustering analysis harbor an
organized gene-expression profile, which can be used to derive
AB
Figure 2. Dopamine Neurons Cluster into
Distinct Subtypes
(A) Out of 159 cells, 55 cells (35%) belong to the first
cluster, 98 cells (61%) were assigned to the second
cluster, whereas six cells (4%) could not be
assigned. Overall, clustering analysis identified six
DA subtypes, represented in a roughly similar pro-
portion in all three microfluidic arrays. The first
cluster can be subdivided into two subtypes,
referred to as DA1A and DA1B, which are composed
of 33 cells (21%) and 22 cells (14%), respectively.
The second cluster can be subdivided into four
molecularly distinct subtypes, labeled DA2A (18%),
DA2B (23%), DA2C (12%), and DA2D (9%).
(B) We compared the gene-expression level
normalized to Gapdh between the two identified
clusters. Genes previously reported to be overex-
pressed in the VTA are illustrated in blue and genes
overexpressed in the SNc illustrated in red (see
Table S1 for references). This quantitative analysis
demonstrates the similarity between the gene-
expression profile of cluster 1 and previously re-
ported profile of SNc, as well as the similarity
between cluster 2 and previously reported profile of
the VTA.
All error bars are SEM.a molecular bar code unique to each subtype (Figure 3). To gain
further insight into the data, we used principal-component anal-
ysis (PCA) to identify components responsible for the variance
observed. Applied to the expression data of the 159 cells, we ex-
tracted four principal components (PCs) and found that the first
principal component (PC1) underlies 22.1%of the observed vari-
ance, PC2 contributes 13.8% to the variance, whereas PC3 and
PC4 contribute to 8.7% and 6.7% of the variance, respectively.
Together, these four PCs account for more than 50% of the vari-
ation of the data set. The first cluster is divided into DA1A and
DA1B and both express high levels of Ndnf, Sox6, and Sncg
mRNA, and the loading of these genes’ contribution to PC1 are
0.237 (Ndnf), 0.232 (Sox6), and 0.145 (Sncg; Figures 3A, 3B,
and S5A). However, the high expression of Aldh1a1 in DA1A, a
gene absent from DA1B, as well as the higher expression of
Snca gene, allowed us to differentiate these two populations
(Figures 3A and 3B). In contrast, Igf1 is more highly expressed
in DA1B compared to DA1A. Interestingly, all these genes
contribute significantly to PC3 and thus allowed us to segregate
those two populations by PCA (Figure 3A).
In order to validate these results and anatomically localize
these DA subtypes in the adult midbrain, we used a combination
of immunofluorescence, fluorescent in situ hybridization, and
transgenic mice. The majority of DA1A neurons are located in
the ventral tier of the SNc (Figure 4A), with a few cells observed
in RR. In those two regions, Aldh1a1 labels 36.7% ± 1.8% and
12.1% ± 2.3% of DA neurons, respectively, overall accounting
for approximately 15.4% ± 1.3% of all midbrain DA neurons.Cell Reports 9, 930–943,Within the DAergic field, Aldh1a1 antibody
overwhelmingly labeled DA neurons (Fig-
ure S6), with occasionally one cell per sec-
tion appearing negative for Th. Within theSNc, Aldh1a1+ neurons are located in the ventral tier and are
also immunolabeled by Sncg and Sox6 but are not labeled
with Calb1 and Otx2 antibodies (Figure 4A). These neurons
also coexpressed Aldh1a1 and Sncg mRNA, which is in com-
plete agreement with our single-cell expression profile of DA1A
cells (Figure 3A). Indeed, according to the array, only the DA1A
subtype expresses a combination of Aldh1a1, Sox6, and Sncg
but do not express Otx2 and Calb1. In contrast to DA1A, DA1B
neurons are located in the dorsal part of the SNc and inter-
mingled with other DA subtypes in the rostro-dorsal VTA (Fig-
ure 4B). These neurons are Sox6+ and Sncg+ but negative for
Aldh1a1. Moreover, Calb1 was variably expressed in Sox6-
positive cells of DA1B, which also appear to mirror the single-
cell array data, whereby varying levels of Calb1 mRNA were
detected in this population.
The second cluster can be defined by a particularly high
expression of Calb1, Slc17a6, and Cck, among others, and can
be further divided into four DA subtypes (DA2A–DA2D), each
defined by a unique molecular signature (Figures 3C–3F). Sub-
type DA2A is specifically defined by the expression of the
GABA vesicular transporter Slc32a1 (also known as Vgat),
because this gene is not significantly expressed by any other
subpopulation (Figures 3C and S5A). This opens the intriguing
possibility that DA2A may corelease GABA, and it is conceivable
that this subtypematches a described DA population sending an
inhibitory projection to the lateral habenula (Stamatakis et al.,
2013). Notably, these cells did not reliably express Gad1, a key
GABA synthesis gene, ruling out the possibility of GABAergicNovember 6, 2014 ª2014 The Authors 933
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neuron contamination. This DA subtype is also uniquely defined
by low expression of a list of genes, which includes Th, Satb1,
Clstn2, Gsg1l, Zfhx3, and Tacr3 (Figure S5). Interestingly, all
these genes contribute significantly to PC4, which allowed us
to segregate DA2A from the other populations (Figure 3C). In or-
der to validate the molecular bar code obtained from our single-
cell approach, we aimed at localizing DA2A neurons in the adult
brain. Because Slc32a1 immunoreactivity is localized in den-
drites and is also present in GABAergic neurons, coimmunolab-
eling analyses proved challenging. Therefore, we crossed
Slc32a1::Cre knockin line to a nuclear LacZ (nLacZ) reporter (Fig-
ure 5A; see Experimental Procedures for details). Although
nLacZ was present in a large number of neurons, presumably
GABAergic, confocal analysis revealed in some cells the coloc-
alization of nLacZ with several markers of midbrain DA neurons
including Th, Nr4a2, and FoxA2 as shown in Figure 5A. These
neurons were found to be intermingled with other cell types
within the VTA, interfascicular nucleus (IF), and caudal linear nu-
cleus (CLI) regions. Quantification of nLacZ and Nr4a2 colabeled
cells shows that subtype DA2A might comprise approximately
14.4% ± 3.8% of DA neurons of the VTA but only about 10%
of the IF/CLI. We also observed the colocalization of Slc32a1
and Th mRNA, supporting our single-cell quantitative PCR
(qPCR) and Slc32a1::Cre recombination data (Figure 5A).
Subpopulation DA2B is uniquely defined by high/exclusive
expression of Lpl, Otx2, and Adcyap1 as well as Grp (Figures
3D and S5). These genes contribute strongly to PC2 to the order
of 0.355 (Lpl), 0.221 (Otx2), 0.242 (Adcyap1), and 0.309 (Grp).
This population displays also strong expression of Aldh1a1
but, contrary to DA1A, which also expresses Aldh1a1, DA2B de-
picts high levels of Calb1 and other molecular determinant of
the second cluster. Subtype DA2B can be isolated by plotting
cells according to PC3 and PC2 (Figure 3D). We validated the
localization of some of those markers in the adult mouse brain.
We could locate subtype DA2B neurons by colabeling of Aldh1a1
and Otx2 (Figure 5B), a combinatorial code unique to this DA
subtype. Aldh1a1+ neurons composed approximately 18.7% ±
2.4% of the DA neurons of the VTA, 52.3% ± 5.1% of the IF,
and 17.5% ± 2.3% of the CLI. Together, Aldh1a1+ neurons in
these regions account for 11.3% ± 1.3% of all midbrain DA neu-
rons. The marker Otx2 is less specific to DA neurons with
numerous Th-negative cells observed within the VTA and neigh-
boring regions (e.g., interpeduncular nucleus; Figure 5B). Within
the VTA, IF, and CLI, more than 60%of Aldh1a1-labeled DA neu-
rons were also positive for Otx2. These cells contain high levels
of Calb1 but are negative for Sox6 and Sncg (not shown), which
confirms the single-cell expression profile obtained with theFigure 3. The Distinctive Molecular Signatures of the Six Dopamine Ne
The normalized expression profile of the six DA neuron subtypes is illustrated using
component analysis allows the differentiation of most DA subtypes.
(A) DA1A is the only subtype with high expression of Aldh1a1, Sox6, and Ndnf an
(B) DA1B depicts an expression profile similar to DA1A but lacks Aldh1a1 express
(C) DA2A is characterized by the high expression of Slc32a1 but low expression
(D) DA2B is defined by the unique coexpression of Lpl, Adcyap1, Otx2, and Aldh
(E) No distinctive marker could be identified for subtype DA2C, which also posse
Slc17a6.
(F) DA2D can be identified by the unique expression of Vip, combined with low e
All error bars are SEM.
Carray. This Grp+ DA2B population matches a recently described
DA population that projects to the nucleus accumbens (Ekstrand
et al., 2014).
In comparison to other DA subtypes, DA2C is harder to define
molecularly because it is not uniquely distinguished by expres-
sion of a single gene like other subtypes of the second cluster.
All genes characterizing the second cluster are strongly ex-
pressed in this population (e.g., Calb1, Cck, and Slc17a6), but
none of the markers identifying other subpopulations are
present: Slc32a1 (DA2A), Adcyap1 (DA2B), and Vip (DA2D; Fig-
ure 3E). Interestingly, genes characterizing cluster 1 are also ex-
pressed in this subpopulation, albeit at lower levels (e.g., Sox6
and Igf1, but not Ndnf). Not surprisingly, this subtype could not
be isolated by PCA (Figure 3E). It is also possible that DA2C could
be comprised of multiple DA subtypes that are indistinguishable
by our analyses.
The final DA subtype identified, DA2D, depicts a unique and
well-defined gene-expression profile with the exclusive expres-
sion of Vip (Figure 3F) combined to low/absent expression of
Snca, Chrna4, and Ntf3 (Figures 3F and S5A). Like most cells
belonging to cluster 2, these cells express Calb1, Cck, and
Foxa2 but do not express Sox6 and Ndnf. In the adult mouse
brain, these neurons are located in the periaqueductal gray
(PAG) and dorsal raphe nucleus (Figure 5C). Within the PAG,
we observed that, in the Slc6a3::Cre/Ai9 mouse, about
48.7% ± 1.2% of tdTomato-positive cells expressed Vip. On
the other hand, 50.0% ± 1.3% of Vip+ cells were labeled with
tdTomato, suggesting that some cells of this population could
have evaded recombination due to very low Slc6a3 expression
level. Vip-labeled DA neurons coexpress most DAergic markers
including Th and FoxA2, but little to no expression of Sox6, Sncg,
Aldh1a1, and Otx2 (Figure 5C; data not shown) was detected by
immunofluorescence in the adult brain. Interestingly, for subtype
DA2D, we were able to take advantage of strong Vip immunolab-
eling to visualize its projections in Slc6a3::Cre; Ai9 mice (Fig-
ure 5D). Vip immunoreactivity is found only in a subset of the
DA projections. Whereas DA projections are extensive in the
extended amygdala, Vip immunolabeling is only observed in
the oval portion of the bed nucleus of the stria terminalis (BSTov)
and the lateral portion of central nucleus of the amygdala (CEAl).
High-magnification images of fibers depict the colocalization of
Vip and tdTomato in axonal boutons of DA neurons terminating
in the BSTov and CEAl (Figure 5D, inset). Vip labeling is excluded
from other DA fields including the lateral septum (Figure 5D),
striatum, accumbens, and cortex. This labeling is consistent
with retrograde tracer analysis showing a dopaminergic
projection from the PAG/dorsal raphe (DR) directed toward theuron Subtypes
18 key genes. Plotting cells on the four extracted components of the principal-
d low expression of Foxa2 and Lmx1a.
ion.
of Satb1, Gsg1l, and Clstn2.
1a1.
sses some similarity with DA1B, if it was not for high levels of Calb1, Cck, and
xpression of Snca, Chrna4, and Ntf3.
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Figure 4. Molecular and Neuroanatomical Characterization of
Dopamine Neuron Subtypes of the First Cluster in the Adult Brain
(A) Subtype DA1A is mainly located in the SNc (red square), with a few cells
observable in the RR (not shown). These neurons are positive for Aldh1a1,
Sncg, and Sox6 but do not show the expression of Calb1 and Otx2.
(B) DA1B subtype neurons are generally located just dorsally to DA1A,
encompassing the dorsal portion of the SNc and dorso-rostral VTA, as well as
RR (not shown). DA1B neurons can be labeled for Sncg and Sox6, but Aldh1a1
is absent in this cell population. The scale bar represents 200 mm (low
magnification) and 50 mm (high magnification). Red square, five neurons
mentioned population; gray square, five DA neurons.
936 Cell Reports 9, 930–943, November 6, 2014 ª2014 The Authorsextended amygdala in the rat (Hasue and Shammah-Lagnado,
2002; Meloni et al., 2006). Overall, the presence and absence
of these markers by colabeling confirms the finding of our
high-throughput single-cell qPCR study as well as validates
the existence of this DA subtypewith distinctive anatomical loca-
tion in the PAG/DR and specific projections within the extended
amygdala in the adult brain.
Finally, we found it useful to examine the expression of various
classes of genes across DA subtypes (Figure S5). We found that
DAsubtypesexhibit distinct transcription factor profiles that could
in part underlie their molecular phenotype. Additionally, neuro-
peptides, channels, and neurotrophic factors were substantially
different between DA subtypes, suggestive of functional hetero-
geneity between these DA subtypes. With respect to PD-related
genes,we found that theseareexpressed inallDAsubtypes; how-
ever, Snca levels are increased in DA1A and DA2B (Figure S5D).
Relevance of Dopamine Neuron Identity to Parkinson’s
Disease
In Parkinson’s disease, DA neurons located in the ventral tier of
the SNc are particularly vulnerable (Damier et al., 1999). Thus,
the DA1A subtype could be of special clinical relevance, because
it is located in the ventral tier of the SNc. To determine if
molecular codes were linked to vulnerability, we evaluated the
susceptibility of DA1A neurons to the neurotoxin 1-methyl-4-
phenyl-1,2,3,6-tetrahydropyridine (MPTP), commonly used to
mimic a number of important pathological features of parkin-
sonism in mice. We observed a significant decrease in the num-
ber of midbrain Th+ cells as quantified by stereological analysis
(4,039 compared to 2,352; p value < 0.01; Figure 6A). As previ-
ously reported (German et al., 1996), cells located in the SNc
were particularly vulnerable (58.0% cell loss; p value < 0.0001),
compared to VTA (39.9% cell loss; p value < 0.005), IF (14.3%
cell loss; p value = 0.5), RR (23.4% cell loss; p value = 0.25),
and CLI (43.3% cell loss; p value < 0.05). We tested the hypoth-
esis that DA1A subtype could be more vulnerable to MPTP toxin
and examined the vulnerability of Aldh1a1-labeled neurons of
SNc and RR (defining DA1A). Indeed, Calb1 and Otx2 genes
that have been associated to resistance to MPTP and PD are
absent in this population (Di Salvio et al., 2010b; Liang et al.,
1996). We found that DA1A neurons were significantly more
vulnerable because we observed a 66.2% diminution of
Aldh1a1+ cells in the SNc and RR of MPTP-treated mice
compared to animals injected with saline (Figure 6B). The re-
maining DA neurons were significantly less affected by MPTP,
with only 39.1% DA cell loss compared to saline (p value =
0.001; Figure 6C). In comparison, DA2B subtype that is defined
by the coexpression Aldh1a1 and Otx2, and is observed in the
ventromedial VTA, is not differently affected by MPTP compared
to other DA populations (Figure 6C). Additionally, when we
counted Aldh1a1-positive and negative cells specifically in the
SNc, we found that Aldh1a1+ cells (DA1A) are significantly
more vulnerable than Aldh1a1 (DA1B) cells to MPTP (Aldha1+
showed 70% loss; Aldh1a1 showed 50% loss; p value =
0.0337). MPTP vulnerability has been in part attributed to levels
of Slc6a3 (Di Salvio et al., 2010b); this latter finding is interesting
as both DA1A and DA1B display high Slc6a3 (Figure S5E), yet the
Aldh1a1+ DA1A cohort appears more vulnerable. Factors other
than Slc6a3 levels may therefore also impact DA neurons vulner-
ability in the MPTP model of PD.
DISCUSSION
This study demonstrates the existence of multiple molecularly
distinct DA neuron subtypes using a single-cell qRT-PCR
approach. These subtypes all share a core genetic program
to produce the neurotransmitter dopamine, upon which sub-
type-specific gene-expression modules are superimposed.
Our high-throughput approach identified several markers related
to specific DA subpopulations and, more importantly, their coor-
dinated expression in single cells. We show that each DA sub-
type has signature expression profiles of transcription factors
(Figure S5B), channels (Figure S5C), receptors (Figure S5C),
DA-related genes (Figure S5E), neuropeptides (Figure S5F),
and secretory factors (Figure S5G). Furthermore, we show that
some of these identified subtypes have distinct anatomical and
functional properties. Our study applies this technology to clas-
sify, in a polythetic manner, neuron subtypes within a neuro-
transmitter group. Although our study focused exclusively on
the DA system, a similar approach could be used to dissect other
neurotransmitter systems within a defined brain region.
Heterogeneous expression of markers in the DA system has
been reported (Di Salvio et al., 2010b; Dougalis et al., 2012; Fu
et al., 2012; Gerfen et al., 1987; Hnasko et al., 2012; McCaffery
and Dra¨ger, 1994; Smits et al., 2013). Previous studies have
relied on in situ hybridization, or antibody colabeling with Th, to
localize marker expression. These studies provided an important
starting point for the classification of DA neuron subtypes pre-
sented here. Because DA neurons are heterogeneous and inter-
mingled, these approaches, whereas informative, do not provide
conclusive evidence of coordinated gene expression, an essen-
tial feature of a neuronal subtype. In contrast, the approach pre-
sented here reveals coordinated expression of cohorts of genes,
thus allowing the classification of DA subtypes in a polythetic
manner, an important goal in the field of neuronal classification
(Bota and Swanson, 2007; Fishell and Heintz, 2013).
Our study has limitations. First, our classification was
achieved in early postnatal brain, at a stage when DA neurons
are still immature in terms of pace-making activity (Chan et al.,
2007) and glutamate receptor expression (Bellone et al., 2011).
It is therefore possible that some markers on which the classifi-
cation is based are specific to this developmental time point.
However, the fact that we could observe all markers that we
tested in the adult brain would argue that our single-cell array
analysis is highly informative, despite the neonatal time point.CSecond, it is possible that DA neurons with low/absent Slc6a3
(Lammel et al., 2008) were excluded from these analyses, due
to inefficient recombination of the reporter by Slc6a3::Cre. Third,
it is possible that there are biases in the dissociation and FACS
method that could disproportionately skew the numbers of
each DA subtype. This could explain the discrepancy between
the proportion of each subtype observed in the array, compared
to what was observed in the adult by immunofluorescence and
in situ hybridization, although these latter methods may also
have inherent bias. Fourth, this method requires some knowl-
edge of gene expression, in this case provided by important
earlier studies (Chung et al., 2005; Greene et al., 2005; Grimm
et al., 2004). Additionally, expanding the number of genes and
cells sampled could increase the power of thismethod and could
yield additional DA subtypes or further subdivide currently iden-
tified DA subtypes. Ultimately, unbiased single-cell mRNA
sequencing could be used to provide further resolution for DA
cell classification. Despite these limitations, this study repre-
sents an important advance; themethod used here allows simul-
taneous, efficient, and quantitative assessment of key DA
markers in single cells. Based on these coordinated gene-
expression profiles, we were able to distinguish multiple molec-
ularly distinct DA subtypes with unique properties, one with a
specific projection, and one selectively vulnerable. Further
work will be required to illustrate the projections, physiological
characteristics, and functions of the DA subtypes defined here.
Defining DA neurons on a molecular basis will allow a better
understanding of the vulnerability of selective DA neuron sub-
sets. In PD, ventral tier SNc neurons are more vulnerable than
either dorsal tier or VTA DA neurons (Damier et al., 1999). Our
data suggest that the Aldh1a1 population in the ventral tier ap-
pears to be particularly vulnerable in an MPTP mouse model. It
is of interest that Aldh1a1, an aldehyde dehydrogenase, is in-
hibited by the fungicide benomyl, for which high exposure was
associated with an increased PD risk (Fitzmaurice et al., 2013).
Additionally, the DA1A subtype is characterized by significantly
lower levels of Foxa2 and En1, as well as higher levels of Snca,
which could in part underpin selective vulnerability in dosage-
sensitive backgrounds (Kittappa et al., 2007; Sgado` et al.,
2006; Singleton et al., 2003). Our data therefore could offer addi-
tional insights into the selective vulnerability of DA neurons.
Understanding the molecular complexity of midbrain DA
subtypes might help refine and develop new therapeutic
approaches for DA-related diseases. Indeed, DA signaling and
receptors are currently the main and potential target in the treat-
ment of PD, schizophrenia, ADHD, addiction, and depression,
among others. An important limitation of current DA therapies
is side effects, largely due to the indiscriminate targeting of the
DA system. For instance, systemic levodopa, themain treatment
for PD, induces psychotic symptoms including hallucinations
and impulsive behaviors in up to 40% of patients (Chou et al.,
2007; Diederich et al., 2009). Conversely, typical and atypical an-
tipsychotics display adverse effects including motor symptoms
such as parkinsonism or tardive dyskinesia. Elucidating DA sub-
typesmay help uncover novel candidates for a newgeneration of
targeted therapeutics.
The stem cell field has highlighted the urgent need to better
understand the molecular basis of DA neuron diversity towardell Reports 9, 930–943, November 6, 2014 ª2014 The Authors 937
(legend on next page)
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Figure 6. DopamineNeuronDA1A Subtype Is
Selectively Vulnerable in an MPTP Model
(A) Example of Aldh1a1 (red) and Th (green) label-
ing in the midbrain of saline- and MPTP-treated
animals.
(B) MPTP induced a significant reduction in Th
immunoreactivity of midbrain neurons.
(C) DA1A subtype is more severely affected by the
toxin as compared to other DA subtypes (labeled
DA1A); in contrast, DA2B does not show differen-
tial vulnerability. The scale bar represents 200 mm
(low magnification).
All error bars are SEM.programming human embryonic or induced pluripotent stem
cells toward specific DA fates (Studer, 2012). DA subtypes
derived from stem cells would serve as more-accurate models
for DA-related disease and would facilitate regenerative medi-
cine. Our study provides a molecular barcode for several DA
subtypes including subtype DA1A, of great interest because of
its location at the ventral aspect of the SNc and its selective
vulnerability. In this regard, revisiting previous lineage analyses
aimed at uncovering distinct DA lineages (Joksimovic et al.,
2009) will benefit from this array of molecular markers. Addition-
ally, our study reveals transcription factor codes that may under-
pin the development of DA heterogeneity (Figure S5B), whichFigure 5. Molecular and Neuroanatomical Characterization of Dopamine Neuron Subtypes of
(A) Subtype DA2A is uniquely defined by the expression of Slc32a1, here mapped using a Slc32a1::Cremous
are bona fide DA neurons, as they can be labeled for Th, Nr4a2 (Nurr1), FoxA2, and Slc6a3 (Dat). These cells a
the VTA.
(B) DA2B neurons can be labeled with Otx2, Aldh1a1, and Calb1 but not Sox6 (not shown). These cells are p
(C) Subpopulation DA2D is located in the periaqueductal gray (PAG) and dorsal raphe (DR) region and can be la
Th and FoxA2 and are labeled by Slc6a3::Cre driver. These cells are also Calb1-positive but negative for Ot
(D) Only subset of midbrain DA neurons axonal projections, as labeled with tdTomato in Slc6a3::Cre/Ai9, colo
subtype DA2D form discrete projections to the oval part of the bed nucleus of the stria terminalis (BSTov) and
apparent boutons colocalizing Vip (green) and tdTomato (red; inset). The scale bar represents 200 mm (low m
square, five neurons mentioned population; gray square, five DA neurons.
Cell Reports 9, 930–943,could be important for embryonic stem
cell programming of DA subtypes.
Finally, the present study provides en-
try points that will allow genetic access
to subtypes of DA neurons. However,
because none of the markers used here
are expressed exclusively in a DA sub-
type, intersectional platforms using multi-
ple recombinase systems would be
required to manipulate these subtypes in
an otherwise intact brain (Awatramani
et al., 2003). Provided with an appropriate
Flp line, these genetic entry points could
be used with mouse genetic-based plat-
forms (Awatramani et al., 2003; Jensen
et al., 2008; Kim et al., 2009; Ray et al.,
2011; Robertson et al., 2013; Yamamoto
et al., 2009) or more recently developed
viral platforms, which allow dual recombi-
nasemediated intersectional gene activa-tion (Fenno et al., 2014). Projection and functional analyses
following intersectional genetic labeling have been successful
in dissecting the connections of serotonin and noradrenergic
populations in the hindbrain (Jensen et al., 2008; Robertson
et al., 2013). In the hindbrain, these neuronal populations span
multiple developmentally defined rhombomeres and therefore
could be dissected using developmentally defined rhombo-
mere-specific Cre lines (Awatramani et al., 2003; Farago et al.,
2006; Jensen et al., 2008; Robertson et al., 2013). In themidbrain
DA system, there are no such convenient segmental divisions.
Thus, our data, providing genetic entry points to defined DA sub-
types, will further facilitate functional investigations usingthe Second Cluster in the Adult Brain
e with a nuclear LacZ reporter (nLacZ). These cells
re intermingled with other DA subtypes throughout
ositioned mainly in the ventromedial VTA and IF.
beled with the Vip antibody. These DA cells express
x2, Aldh1a1, and Slc32a1::Cre.
calized with Vip. These fibers, which originate from
the lateral part of the central amygdala (CEAl), with
agnification) and 50 mm (high magnification). Blue
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chemogenetic or optogenetic technology (Ray et al., 2011; Ro-
gan and Roth, 2011; Tye and Deisseroth, 2012) as well as tran-
scriptomic and connectomic analyses, with the ultimate goal of
disentangling this pleiotropic neurotransmitter system.
EXPERIMENTAL PROCEDURES
Mice and Flow Cytometry
Mice were maintained and euthanized according to the protocols approved by
the Northwestern University Animal Care andUse Committee. The Slc6a3::Cre
and Ai9 mice used in this study were both maintained on C57Bl/6 background
and were described previously (Ba¨ckman et al., 2006; Madisen et al., 2010). In
this mouse, the vastmajority of DA neurons are recombined. For the single-cell
study, the midbrain of three P4 mice were carefully dissected to grossly the
size of 13 23 2 mm. Midbrain neurons were dissociated using Papain Disso-
ciation System (Worthington Biochemical Corporation) according to the man-
ufacturer’s instructions. Cells were resuspended in Neurobasal medium (Life
Technologies), and single cells were immediately sorted in a 96-well plate
with the help of Northwestern University Flow Cytometry Facility and a Cancer
Center Support Grant (NCI CA060553). FACS was performed on an Aria II
SORP sorter using a fine-tune sort precision protocol. This approach provides
a reliable single-cell sorting by adequately calculating the drop delay but also
increases the proportion of empty wells. Three 96-well plates for gene-expres-
sion analysis were filled with single fluorescently labeled neurons, with the
exception of six wells that were used for calibration curves, three wells used
for positive control (10, 20, and 50 cells) and one well used for negative control
(e.g., Figure S1). For immunofluorescence and fluorescence in situ hybridiza-
tion, perfused adult mice (older than P56) were used unless stated otherwise.
Primers Design and Validation
Each primer pair was designed, generated, and experimentally validated by
Fluidigm. Primers were designed to span exon junctions, when possible,
with an average amplicon size of 82 bp (Table S1). Assay performance was
evaluated via serial dilution of a commercial reference sample. The DCT
(or Cq) was calculated for all pairwise combinations of assays and the slope
ofDCT versus log2 template dilution calculated and averaged. Themean slope
of DCT versus template concentration for cDNA templates indicates relative
error in measuring 2-fold changes for the given assay compared to the other
assays (Schmittgen and Livak, 2008). If two assays have equal efficiencies
and there is no measurement error, the slope will be zero. Overall, 98.9% of
assays fell in the range of 0.1 and 0.1.
Single-Cell Gene-Expression qPCR
Cells were sorted directly into 5 ml of the reverse transcription (RT) mix solution
1, composed of 1.2 ml VILO Reaction Mix (SuperScript VILO cDNA Synthesis
Kit; Life Technologies), 0.3 ml 20 U/ml SUPERase-In, 0.25 ml NP-40 Detergent
Surfact-Amps Solution (Fisher Scientific), and 3.25 ml of nuclease-free H2O
(Teknova). RNA was denatured 90 s at 65C. The plate was quickly chilled
on ice for 5 min and centrifuged briefly at 4C. We added 1 ml to each well of
RT mix solution 2 composed of 0.15 ml of 103 SuperScript Enzyme Mix,
0.12 ml of T4 Gene 32 Protein (New England Biolabs), and 0.73 ml of
nuclease-free H2O. Reverse transcription was carried out in thermal cycler
under the following condition: 5 min at 25C, 30 min at 50C, 25 min at
55C, 5 min at 60C, and 10 min at 70C. Subsequently, in the same tube,
cDNA went through sequence-specific amplification by denaturing at 95C
for 15 s and annealing and amplification at 60C for 4 min for 18 cycles. These
preamplified products were diluted 5-fold prior to the analysis with Universal
PCR Master Mix and inventoried TaqMan gene-expression assays (ABI) in
96.96 Dynamic Arrays on a BioMark System (Fluidigm). Ct values were calcu-
lated from the system’s software (BioMark Real-time PCR Analysis; Fluidigm).
For quality control, the melt curve was established and all peaks falling outside
user-defined threshold were removed from analysis (Figure S2).
Single-Cell Data Processing and Analysis
Overall, 274 single-cell were sorted into 96-well plates. Out of these cells, we
removed cells with weak or no expression of Gapdh, defined by greater than940 Cell Reports 9, 930–943, November 6, 2014 ª2014 The Authorstwo SDs from the median, from the analysis. In addition, we removed cells
with weak expression of genes defining DA neurons (Ddc, Th, Slc6a3, and
Slc18a2) using the same criteria. These cells were assumed to be non-DA cells
and were removed from the analysis, leaving a final 159 DA neurons to be
further analyzed. In addition, despite depicting a normal standard curve, two
genes, Pvalb and Aldh1a2, were undetectable in all cells analyzed, and these
genes were thus excluded from further analysis and replaced by the house-
keeping genes Actb and Hprt. All Ct values (e.g., Figure S1) obtained from
the BioMark System were converted into relative expression levels by sub-
tracting the values from the threshold value of 24 (Figures 1B and S3). All Ct
values above 24 were considered below detectability level. As the Ct scale
is logarithmic (a difference of one Ct corresponds to a doubling of measured
transcript), the values obtained were normalized to the endogenous control
by subtracting, for each cell, its Gapdh Ct value (delta Ct). The fold difference
was obtained by using the highest gene expression cell sample for each gene
and used as a reference to calculate the delta delta Ct (comparative Ct
method). In order to group cells with similar expression profile, we used cluster
analysis by correlation coefficient similarity on logarithmic expression data.
Cells were assigned to a specific DA subtype based on this cluster analysis.
To compare gene expression level between identified populations, because
the homogeneity of variance assumption was violated, normalized gene levels
between subtypes were compared between DA subtypes using a Kruskal-
Wallis and Dunn’s post hoc analysis with Bonferroni correction of alpha value.
Immunofluorescence
Staining was performed on adult (more than 2 months of age) wild-type and
Slc6a3::Cre; Ai9 mice for minimum of n = 3 for all antibodies. To map the
DA2A subtype, we crossed a mouse in which Cre was knocked in Slc32a1
locus (Vong et al., 2011), with a Rosa locus reporter in which a floxed
stop cassette was followed by nuclear LacZ RosaNZG (Yamamoto et al.,
2009). Mice were perfused with cold 4% paraformaldehyde (PFA) in PBS,
and the brains were dissected and fixed overnight in the same solution, cry-
oprotected in 30% sucrose PBS solution, and sectioned at 25 mm using a
freezing microtome. Tissue sections were stained with the following primary
antibodies: mouse anti-Calbindin (Sigma-Aldrich; 1:1,000), rabbit anti-
Calbindin (Chemicon; 1:500), rat anti-Dat (Santa Cruz Biotechnology; 1:50),
goat anti-FoxA2 (Santa Cruz; 1:50), goat anti-LacZ (Biogenesis; 1:1,500),
rabbit anti-LacZ (Cappel; 1:1,500), rabbit anti-Nr4a2 (Santa Cruz; 1:500),
goat anti-Otx2 (Neuromics; 1:200), rabbit anti-Aldh1a1 (Abcam; 1:200), rab-
bit anti-Sncg (Abcam; 1:1,000), rabbit anti-Sox6 (Abcam; 1:500), rabbit anti-
Vip (Abcam; 1:500), rabbit anti-SatB1 (Abcam; 1:1,000), and sheep anti-TH
(Pel-Freez; 1:300). Sections were imaged by confocal microscopy (Leica
DM6000 CFS). For each DA subtype mapped in Figures 4 and 5, a combi-
nation of markers specific to this subtype was analyzed. Cells were counted
on representative sections, superimposed to the reference section from the
Allen Brain Atlas, and averaged across animals. Each colored square in Fig-
ures 4 and 5 represents five neurons of the DA subtype at the approximate
location, whereas each gray square represents five DA neurons of another
subtype.
Fluorescent In Situ Hybridization
Fluorescent in situ hybridization (ISH) was performed with single-stranded di-
goxigenin (Roche) and fluorescein-labeled riboprobes directed against the
following mRNAs: Th (GenBank accession number: NM_009377), Aldh1a1
(NM_013467), Ndnf (A930038C07Rik), Slc32a1 (GenBank accession number:
NM_009508), and Sncg (GenBank accession number: NM_011430). The ISH
protocol was adapted from Joksimovic et al. (2009).
MPTP Protocol
Adult C57BL/6 mice (n = 16) received four intraperitoneal (i.p.) injections of
freshly diluted MPTP-HCl (20 mg/kg; Sigma) dissolved in saline 0.9%. MPTP
was administered in an acute manner at 2 hr intervals as previously described
(Jackson-Lewis and Przedborski, 2007). Remaining animals (n = 8) received
i.p. vehicle injections at the time of MPTP administration. Mice were sacrificed
7 days following the last MPTP injection through intracardiac perfusion with
either PBS 0.1 M only or PBS followed by PFA 4%. Brains were collected,
further fixed in PFA, and cryoprotected in 20% sucrose.
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